MedPath

Gradual vs. Abrupt Cessation Treatment for Smoking

Phase 2
Completed
Conditions
Smoking Cessation
Interventions
Behavioral: Abrupt Phone Counseling
Behavioral: Minimal Abrupt Phone Counseling
Behavioral: Reduction Phone Counseling
Drug: Pre-Quit Nicotine Lozenges
Drug: Post-Quit Nicotine Lozenges
Registration Number
NCT00297492
Lead Sponsor
University of Vermont
Brief Summary

This study tests whether stopping smoking by gradually cutting down first is more or less successful than stopping abruptly. We hypothesize that stopping by gradually cutting down first will produce more abstinence than stopping abruptly.

Detailed Description

For cigarette smokers who intend to stop smoking, most treatment guidelines recommend abrupt cessation. There is evidence from some small studies that gradually reducing the number of cigarettes per day smoked may increase success in quitting. In this study, we will randomize smokers who want to quit smoking in the next 30 days to one of three groups: gradual reduction, abrupt cessation, and minimal intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
750
Inclusion Criteria
  • Interested in quitting gradually
  • At least 18 years old
  • Daily cigarette smoker
  • Smoke at least 15 cigarettes per day (CPD)
  • No change greater than 20% in CPD in the last month
  • Interested in quitting in next 30 days
  • Must agree to not use non-cigarette tobacco during study
  • No use of smoking cessation medication in last month
  • Have phone with voice mail
  • Willing to use nicotine lozenge
  • No other person in household in study
  • Fluent/literate in English
Read More
Exclusion Criteria
  • Women who are pregnant or breastfeeding
  • Currently using medication for depression or asthma
  • Heart disease requiring medication
  • Heart attack in last month
  • Irregular heartbeat
  • High blood pressure not controlled by medication
  • Stomach ulcers
  • Diabetes
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Gradual reductionPost-Quit Nicotine LozengesIntervention: Reduction Phone Counseling. Intervention: Pre-Quit Nicotine Lozenges. Intervention: Post-Quit Nicotine Lozenges.
Abrupt cessationAbrupt Phone CounselingIntervention: Abrupt Phone Counseling. Intervention: Post-Quit Nicotine Lozenges.
Abrupt cessationPost-Quit Nicotine LozengesIntervention: Abrupt Phone Counseling. Intervention: Post-Quit Nicotine Lozenges.
Minimal interventionMinimal Abrupt Phone CounselingIntervention: Minimal Abrupt Phone Counseling. Intervention: Post-Quit Nicotine Lozenges.
Minimal interventionPost-Quit Nicotine LozengesIntervention: Minimal Abrupt Phone Counseling. Intervention: Post-Quit Nicotine Lozenges.
Gradual reductionReduction Phone CounselingIntervention: Reduction Phone Counseling. Intervention: Pre-Quit Nicotine Lozenges. Intervention: Post-Quit Nicotine Lozenges.
Gradual reductionPre-Quit Nicotine LozengesIntervention: Reduction Phone Counseling. Intervention: Pre-Quit Nicotine Lozenges. Intervention: Post-Quit Nicotine Lozenges.
Primary Outcome Measures
NameTimeMethod
Number of Participants With Prolonged Abstinence Through 6 Months Verified by Carbon Monoxide Measurement6 months

Number of participants with self-reported prolonged abstinence from cigarette smoking through 6 months of follow-up, verified by a breath carbon monoxide reading of less than 10 parts per million

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Vermont Human Behavioral Pharmacology Lab

🇺🇸

Burlington, Vermont, United States

© Copyright 2025. All Rights Reserved by MedPath